Analyst Ratings for Oncothyreon (ONTY) [Buys]
ONTY Rating Summary
ONTY Price Target Summary
- Highest: $14.00 (JMP Securities)
- Lowest: $1.00 (Piper Jaffray)
- Average: $7.25
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$7.25 (+307.3%)
Avg. $ Target:
$7.25 (+307.3%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/17/2013 | Wedbush | Upgrade | Outperform (Neutral) |
N/A (N/A) |
1.97 | 1.78 | -9.64% | Details |
| 8/24/2012 | Stifel Nicolaus | New Coverage | Buy (N/A) |
10.00 (N/A) |
4.37 | 1.78 | -59.27% | Details |
| 1/25/2012 | Cantor Fitzgerald » Updated 3/15/2013 |
New Coverage | Buy (N/A) |
4.00 (11.00) |
6.32 | 1.78 | -71.84% | Details |
| 5/31/2011 | Cowen | New Coverage | Outperform (N/A) |
N/A (N/A) |
6.43 | 1.78 | -72.32% | Details |
| 4/25/2011 | Rodman & Renshaw | New Coverage | Market Outperform (N/A) |
N/A (N/A) |
4.47 | 1.78 | -60.18% | Details |
| 8/13/2010 | JMP Securities » Updated 1/24/2012 |
New Coverage | Market Outperform (N/A) |
14.00 (N/A) |
3.53 | 1.78 | -49.58% | Details |
